Table 2.
Comorbidities at assessment for heart transplantation
| All | LV | RV | SV | P values | |
| n=196 | n=53 | n=57 | n=86 | ||
| Previous sternotomies | 1 (0–5) | 2 (1–5) | 1 (0–4) | 2 (0–5) | <0.001 |
| Transpulmonary gradient (mm Hg) | 6 (4–11) | 6 (4–10) | 12 (6–17) | 5 (4–7) | <0.001 |
| PCWP/ventricular EDP (mm Hg) | 13 (10–24) | 18 (10–26) | 23 (12–30) | 12 (9–14) | <0.001 |
| MPAP (mm Hg) | 20 (15–35) | 24 (15–38) | 37 (20–45) | 17 (13–21) | <0.001 |
| Creatinine (µmol/L) | 98 (82–120) | 93 (79–129) | 100 (88–119) | 94 (79–118) | 0.179 |
| Renal replacement therapy | 2 | 1 | 0 | 1 | |
| Diabetes mellitus | 3 | 0 | 3 | 0 | |
| Thyroid dysfunction | 18 | 6 | 3 | 9 | |
| Neurological (prior stroke/cerebral abscess/epilepsy/head injury) | 23 | 6 | 7 | 10 | |
| Chromosomal abnormality | 1 | 1 | 0 | 0 | |
| Liver disease (viral hepatitis) | 19 | 2 | 2 | 15 | |
| Protein losing enteropathy | 7 | 0 | 0 | 7 |
EDP, end diastolic pressure; LV, left ventricle group; MPAP, mean pulmonary artery pressure; PCWP, pulmonary capillary wedge pressure; RV, right ventricle group; SV, single ventricle group.